University Hospital of Reims
Welcome,         Profile    Billing    Logout  
 9 Trials 
18 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pluchart, Claire
HR-NBL2, NCT04221035 / 2019-001068-31: High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

Recruiting
3
800
Europe, RoW
Vincristine, L01CA02, Carboplatin, LO1XA02, Etoposide, L01CB01, Vindesine, L01CA03, Dacarbazine, L01AX04, Ifosfamide, Doxorubicin, L01DB01, Busulfan, L01AB01, Melphalan, L01AA03, Thiotepa, L01AC01, Radiotherapy, Dinutuximab Beta, L01XC16, Cisplatin, L01XA01, Temozolomide 100 MG, Irinotecan, Cyclophosphamid
Gustave Roussy, Cancer Campus, Grand Paris, PHRC, Solving Kids' Cancer Europe, Neuroblastoma UK, , BSPHO, Instituto de Investigación Sanitaria La Fe, Deutsche Krebshilfe
High-Risk Neuroblastoma, Patient With Insufficient Response Chemoimmunotherapy
11/26
11/32
ALLTogether1, NCT04307576 / 2018-001795-38: A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

Recruiting
3
6430
Europe, RoW
Omitted Doxorubicin, Omitted Vincristine+Dexamethasone pulses, Inotuzumab Ozogamicin+Standard Maintenance Therapy, Besponsa+Maintenance Therapy, Imatinib, 6-tioguanine+Standard Maintenance Therapy, Blinatumomab, Blincyto
Mats Heyman, The Swedish Research Council, The Swedish Childhood Cancer Foundation, Pfizer, Servier, NordForsk, Aamu Pediatric Cancer Foundation, German Society for Pediatric Oncology and Hematology GPOH gGmbH, Clinical Trial Center North (CTC North GmbH & Co. KG), Belgium Health Care Knowledge Centre, Karolinska Institutet, Cancer Research UK, Fundação Rui Osório de Castro, Acreditar - Associação de Pais e Amigos das Crianças com Cancro, Grupo Português De Leucemias Pediátricas, Amgen, Nova Laboratories Limited, Danish Child Cancer Foundation, Danish Cancer Society, The Novo Nordic Foundation, Assistance Publique - Hôpitaux de Paris, Direction Générale de l'Offre de Soins
Leukemia, Acute Lymphoblastic
06/27
06/32
SIOP-EP-II, NCT02265770 / 2013-002766-39: An International Clinical Program for the Diagnosis and Treatment of Children With Ependymoma

Recruiting
2/3
536
Europe, RoW
16 weeks of VEC + CDDP, Vincristine, Etoposide, Cyclophosphamide, Cisplatin, VEC + HD-MTX, Methotrexate, Chemotherapy + Valproate, Carboplatin, Valproate, Conformal radiotherapy, VEC, Chemotherapy, conformal radiotherapy +/- boost
Centre Leon Berard
Childhood Ependymoma
06/28
08/31
RETINO2018, NCT04681417 / 2019-005039-94: Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome

Recruiting
2/3
225
Europe
Melphalan or Melphalan + Topotecan, Alkeran, Topotecan Accord; Topotecan Hospira chemotherapy, etoposide, carboplatin and vincristine or local ophthalmological treatment without IV chemotherapy, etoposide, carboplatin and vincristine chemotherapy, Carboplatin administered on Day 1, platinum-based chemotherapy, Thermotherapy (local treatment), Thermotherapy after carboplatin administered on Day 1, Cryotherapy (local treatment), Iodine-125 plaques (local treatment), Intravitreal Melphalan chemotherapy injections (local treatment)
Institut Curie, Fondation Rothschild Paris
Retinoblastoma
01/35
01/36
RETINO2011, NCT02866136: Conservative Treatments of Retinoblastoma

Active, not recruiting
2
133
Europe
VP16, carboplatin, etoposide, vepesid, chemotherapy, Melphalan, Alkeran, chemotherapy, VP16, carboplatin, vincristin, etoposide, vepesid, leurocristine, Oncovin, chemotherapy, Carboplatin + laser day 1 (chemothermotherapy), Carbo-laser, platinum-based chemotherapy, Laser (local treatment), Laser diode, cryoapplication (local treatment), I125 radioactive plaques (local treatment), intravitreal Melphalan (local treatment)
Institut Curie, Fondation Rothschild Paris
Retinoblastoma, Children, Retinal Neoplasm
01/23
09/35
NCT02870907 / 2009-016448-38: Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009)

Recruiting
2
185
Europe
Observation, Low risk group, Etoposide, Intermediate risk sub group 1, Vincristine, Intermediate risk sub group 2, Orbital irradiation, High risk group, Carboplatin, Cyclophosphamide, Thiotepa, Cytapheresis, Peripheral bood stem cell transplantation
Institut Curie
Retinoblastoma
03/30
09/30
NEUROBLU 02, NCT03966651 / 2020-002996-36: A Clinical Study Evaluating the Safety of Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-DOTA0-Tyr3-Octreotate in Children With Refractory or Recurrent Neuroblastoma Expressing Somatostatin Receptors.

Recruiting
1
18
Europe
PRRT with 177Lu-DOTATATE
Institut Claudius Regaud, Advanced Accelerator Applications
Neuroblastoma
10/25
02/26
NCT03306251: National Cohort of Children Born to HIV-positive Mothers

Recruiting
N/A
5200
Europe, RoW
ANRS, Emerging Infectious Diseases
Mother to Child Transmission of HIV
03/23
03/23
CURALASE01, NCT04596410: Photobiomodulation Protocols in the Analgesia of Chemotherapy-induced Oral Mucositis in Children

Recruiting
N/A
406
Europe
LLLT applied every other day, LLLT applied daily
University Hospital, Toulouse
Mucositis Oral
01/24
02/24
ESCORT-HU Extension, NCT04707235: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study

Active, not recruiting
N/A
2093
Europe, RoW
Hydroxycarbamide, Siklos, Hydroxyurea
Theravia, International Clinical Trials Association
Sickle Cell Disease
08/25
08/25
MICCHADO, NCT03496402: Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults

Active, not recruiting
N/A
600
Europe
Sampling on blood, bone marrow and cerebrospinal fluid
Institut Curie
Neuroblastoma, Rhabdomyosarcoma, Ewing Sarcoma Family of Tumors, Osteosarcoma, Leukemia, Central Nervous System Tumor
04/27
08/27
MAPPYACTS2, NCT05691608: MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2

Recruiting
N/A
1800
Europe
Solid tumor and CT DNA
Gustave Roussy, Cancer Campus, Grand Paris
Solid Tumor, Leukemia
09/30
09/30
ALARM3, NCT05772559: Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in Children, Teenagers and Young Adults: Molecular Profiling, Multidrug Testing and MSC Interaction Studies

Recruiting
N/A
500
Europe
Collection of blood sample of bone marrow (cohort 1), Collection of blood sample of bone marrow (cohort 2 and 3)
Assistance Publique - Hôpitaux de Paris
Acute Myeloid Leukemia, Genetic Predisposition to Disease
05/33
05/33
BIOPORTAL, NCT05192980: SIOPEN , An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours

Recruiting
N/A
600
Europe
No Intervention NA, Bio-sampling
Institut Curie
Neuroblastoma, Ganglioneuroblastoma, Ganglioneuroma
11/38
11/38
COLOSIO, Charlotte
OXYOP 2, NCT04181710: Evaluation of a Marine OXYgen Carrier for Organ Preservation

Completed
N/A
490
Europe
Kidney transplant
University Hospital, Brest
End Stage Renal Diseases
07/22
09/23
LINE, Antoine
LaparoDAN, NCT04174807: Prospective Study of Antenatal Diagnostic Criteria for Digestive Complications of Gastroschisis

Recruiting
N/A
200
Europe, RoW
University Hospital, Angers
Gastroschisis, Intestinal Occlusion
05/22
05/22
WEIRAUCH, Nathalie BEDNAREK
EPIREMED, NCT02757794: Long-term Effects of Visual Spatial Working Memory Training Program Performed at Preschool Age in Very Preterm Infants With Visual Spatial Working Memory Deficit. A Randomized Controlled Trial

Completed
N/A
166
Europe
computerized cognitive remediation program, standard remediation
Assistance Publique Hopitaux De Marseille
Children Born Extremely Premature, Disturbance of Visuo-spatial Working Memory
08/19
08/19
Delepine, Beatrice
FERTITOP, NCT05048771: Fertility and Temporality in Pediatric Oncology

Not yet recruiting
N/A
300
Europe
Questionnaire, Interview
Central Hospital, Nancy, France, National Cancer Institute, France
Fertility Issues, Childhood Cancer, Psychology, Social
12/23
03/24

Download Options